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Abstract
Background: Although liver resection has become an established procedure in western countries and South-east Asia it is
still not performed frequently in most centres in India. In the last 10 years newly created specialized units have been
performing more liver resections but no major series have been reported. Patients and methods: We analysed the results of
241 hepatic resections in the Gyan Burman Liver Unit, Sir Ganga Ram Hospital to compare our results with those
published from established centres and to identify the factors relating to morbidity and mortality. To examine the effect of a
greater experience with the procedure we compared the outcome of our operations from 19962000 (first period) and those
from 20012005 (second period). Results: The overall mortality and morbidity rates were 6.6% and 44.8%, respectively,
which are comparable with those of most recently published Western series. Life-threatening complications occurred in
12.4% patients. Multivariate analysis showed that the presence of comorbid conditions, intraoperative blood transfusions of
/3 units, hepatocellular carcinoma with underlying cirrhosis and gall bladder carcinoma with jaundice were the
independent risk factors for morbidity, whereas the presence of comorbid illness and underlying liver cirrhosis were the risk
factors for mortality. During the second period there was an increase in the number of operations performed (66 vs 175; first
vs second period), but the mortality rates remained essentially unchanged (6.1% vs 6.8%). Discussion: Hepatic resections
can be performed safely in India with results comparable to those achieved in the West. Increasing experience did not reduce
overall mortality. Perhaps more careful patient selection and better perioperative management of comorbid illnesses may
reduce the morbidity and mortality further.
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Introduction
The results of liver surgery have improved dramati-
cally in the last 20 years. There has been a major
decrease in perioperative mortality from 20% to B/5%
in high volume centres [1,2] and this improvement
has probably been due to a better understanding of
hepatic anatomy, the use of hypotensive anaesthesia,
better patient selection and the emergence of hepato-
biliary surgery as a subspeciality [2,3]. All this has
occurred in spite of the extension of the indications
for hepatic resection to include conditions like recur-
rent hepatocellular carcinoma and metastatic disease,
hilar bile duct carcinoma and living related donor
transplantion [4].
However, although there has been an improvement
in overall survival, recent reports indicate that mor-
bidity and mortality rates are still high after hepatic
resection in patients with liver cirrhosis and jaundice,
emphasizing the need for judicious patient selection
[3,5,6]. Reports of large numbers of patients have
been mainly from Western countries and the Far East
but there have been none from South Asia. We
analysed 241 consecutive cases of hepatic resections
undertaken in a tertiary referral centre in India to
define the risk factors associated with postoperative
morbidity and mortality. We also compared our
results with those of other centres and examined
whether experience with the procedure made a
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difference by contrasting our results obtained between
19962000 and 20012005.
Patients and methods
Between 1996 and 2005, we performed 241 hepatic
resections in our department and recorded the details
in a prospectively maintained database. All the
patients underwent a thorough history and physical
examination and any associated comorbid conditions
were managed appropriately. The operation was done
through an extended right subcostal incision or a
bilateral subcostal incision with a vertical midline
extension. Details of the technique of hepatectomy
have been described elsewhere [2]. In the first half we
frequently used the Pringle manoeuvre (clamping of
the portal triad for 15 min alternating with a 5 min
release) and in the second half this was rarely
employed. For parenchymal transection, the Kelly
fracture technique was used during the first half of the
study and the Cavitron Ultrasonic Surgical Aspirator
(CUSA) was mainly used during the second half. In
donors who were undergoing partial hepatectomy for
liver transplantation, only CUSA was used for dissec-
tion so that the vessels and bile channels were not
traumatized. Haemostasis was obtained during par-
enchymal transection using a combination of dia-
thermy, argon beam coagulation and suturing.
The intraoperative variables we analysed included
whether the procedure was an emergency or done
electively, whether major (two or more segments
removed) or minor hepatic resection was done,
whether associated procedures were performed and
whether the Pringle manoeuvre was used, and we
recorded the resection technique, the volume of blood
transfusion and the duration of surgery. The asso-
ciated procedures performed with hepatic resection
were considered only if they were likely to affect the
outcome of surgery, e.g. organ resection, bile duct
excision and reconstruction, portal vein or vena cava
resection and lymphadenectomy at the porta hepatis.
Such cases were labelled complex hepatectomies.
Cholecystectomy and common bile duct exploration
with T-tube drainage were not considered to be
‘associated’ procedures.
The postoperative variables analysed included
minor or major complications, the duration of hospi-
tal stay and mortality (within 30 days of operation or
during the same hospital admission). Complications
were considered to be major only when they resulted
in organ failure or required another operation or
radiological intervention. Wound infection, transient
ascites, minor bile leaks, jaundice and liver dysfunc-
tion responding to conservative treatment were con-
sidered to be minor complications. Pathological
details on the resected specimens were obtained
from the laboratory reports. Apart from the size and
extent of the primary lesion in the liver, any under-
lying parenchymal abnormality (e.g. cirrhosis, fibrosis
or steatosis) was recorded.
Statistical analysis
Continuous variables were depicted as the median
value (range) and compared using the independent
samples t test. Categorical variables were compared
using the x2 test with Yates’ correction or Fisher’s
exact test. Multivariate analysis was performed using a
stepwise logistic regression analysis. Statistical signifi-
cance was defined as pB/0.05. All statistical analyses
were performed using the statistical software package
Statistical Package for the Social Sciences (SPSS,
Chicago, IL, USA).
Results
There were 119 men and 122 women who underwent
hepatic resection for benign or malignant hepatobili-
ary disease. The preoperative characteristics of the
patients are provided in Table I. The most common
comorbid condition was hypertension (13.7%), fol-
lowed by diabetes mellitus (10.4%). The patients
operated in the first and second half of the study
period were comparable with respect to comorbid
factors.
Table I. Patient demographic and comorbid conditions (n/241).
Parameter Value
Male/female (n ) 144/97
Age (years) 47.839/15.15 (182)
Patients with ]/1 comorbid
conditions, n (%)
77 (2%)
Patients with ]/2 comorbid
conditions, n (%)
17 (7.1%)
Hypertension 33 (13.69%)
Diabetes mellitus 25 (10.37%)
Cardiac disease 13 (5.39%)
COPD 10 (4.15%)
Chronic renal failure 6 (2.45%)
Others* 8 (3.32%)
HBsAg positivity$, n (%) 15 (6.2%)
Haemoglobin B/10 g/dl 25 (11.2%)
Serum bilirubin /2 mg/dl 52 (21.6%)
Serum bilirubin /10 mg/dl 25 (10.4%)
Serum albumin B/3.5 g/dl 67 (28.8%)
Platelet count B/150 000/ml 24 (10%)
Serum creatinine /1.3 mg/dl 12 (5%)
Abnormal serum alkaline
phosphatase, n (%)
65 (27%)
Abnormal serum transaminases,
n (%)
33 (14.2%)
Abnormal prothrombin time,
n (%)
22 (9.1%)
COPD, chronic obstructive pulmonary disease.
*Obesity (2), peripheral vascular disease (2), hypothyroidism (1),
thyroiditis (1), major depression (1), transient ischaemic attack 
TIA (1).
$Not all patients were routinely tested.
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Operative variables
Table II and Figure 1 depict the indications for
hepatectomies and the types of procedures per-
formed. The most common indication for hepatic
resection was carcinoma of the gall bladder, which
accounted for 36.1% of all cases. In all, 111 (46.1%)
patients underwent major hepatic resections, whereas
the other 130 (53.9%) underwent minor hepatic
resection of two or fewer segments (Table III).
Complex hepatectomies were done in 86 patients
(35.7%). The average operation time was 330 (range
110840) min (Table IV). The Pringle manoeuvre
was used in 42.7% of cases and CUSA was used in
42.3% of cases for parenchymal transection. The
average amount of blood transfusion required dur-
ing surgery was 2.4 (08) units (one unit equaling
450 ml). Twenty-one major and 27 complex hepatec-
tomies were performed during the first period and 90
major and 59 complex hepatectomies were performed
during the second period. The average duration
of surgery was significantly higher in the second
period (354 min) compared with the first (266 min)
(pB/0.001). The average blood transfusion require-
ment during operation was 2.5 units during the first
half and 2.3 units during the second half of the study.
Morbidity
The overall morbidity rate was 44.8% (108) and
major complications were seen in 30 (12.4%) cases
(Table IV). Thirty-eight (15.8%) patients developed
two or more complications in the postoperative
period. The most common complications were as-
cites, hepatic insufficiency and bile leaks, which
usually resolved with conservative treatment. The
major complications requiring re-exploration and/or
image-guided intervention were intra-abdominal hae-
morrhage, pleural effusion and portal vein thrombo-
sis. The morbidity rate of patients with underlying
cirrhosis was 85% (17/20) and in patients without
underlying cirrhosis was 41.2% (91/221) and this
difference was statistically significant (pB/0.001).
Table II. Indications for hepatic resection (n/241).
Indication n (%)
Benign 84 (34.9%)
Malignant 157 (65.1%)
Biliary malignancy
Gall bladder carcinoma 87 (36.1%)
Hilar cholangiocarcinoma 12 (5%)
Primary liver tumor 37 (15.4%)
Hepatocellular carcinoma (33)
Hepatoblastoma (3)
Embryonal carcinoma (1)
Non-Hodgkins lymphoma (1)
Metastatic liver tumours 19 (7.9%)
Colorectal metastasis (11)
From other site* (8)
Haemangioma 17 (7.1%)
Hydatid cyst 11 (4.6%)
Liver trauma 10 (4.1%)
Living donor liver transplant 31 (12.9%)
Other benign diseases$ 16 (6.6%)
Other malignancy% 1 (0.4%)
*Stomach (3), adrenal gland (1), neuroendocrine tumor (1),
pancreas (1), unknown (2).
$Biliary stricture (6), liver abscess (3), simple liver cysts ( 2),
Caroli’s disease (2), hepatolithiasis with left lobe atrophy (1),
haemobilia with right hepatic artery pseudoaneurysm (1), chronic
cholecystitis mimicking carcinoma of gall bladder (1).
%Recurrent liposarcoma infiltrating into the liver (1).
241 patients
Hepatic resection +
additional major procedures
86 (35.7%))
(Complex hepatectomies)
Hepatic resection only
155 (64.3%)
Extrahepatic procedures
84 (34.9%)
Additional hepatic procedures
10 (4.1%)
Wedge excision (4)
Segmental resection (3)
Enucleation (3)
Biliary procedures (59)
Major organ procedures (20)
-Colon & rectum (8)
-Stomach (5)
-Adrenal (3)
-Portal vein reconstruction (2)
-Lungs (1)
-Spleen (1)
Orthopaedic (2)
Others (3)
Figure 1. Details of operative procedures in patients undergoing hepatic resection.
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Postoperative hospital stay
The overall median length of postoperative hospital
stay was 10.2 days (range 341 days); 63.5% (153)
patients were discharged within 10 days of surgery
and 36.5% (88) patients had a hospital stay of /10
days. The lengths of stay during the first and second
halves of the study were 10.8 days and 9.9 days,
respectively, and this difference was not significant
(p/0.70).
Mortality
There were 16 postoperative deaths (6.6%). The
mortality rate was higher after resection for malignant
disease than after resection for benign disease (8.3%
vs 3.6%) and the mortality rate in cirrhotic patients
was higher than in non-cirrhotic patients (30% vs
4.5%, p/0.001). After major hepatectomy the mor-
tality was 6.3% (7/111) and 9.3% (8/86) after com-
plex hepatectomies. The complications leading to
death included postoperative renal failure (n/8),
hepatic failure (7), multi-organ failure (3), septicae-
mia (3), respiratory failure (2), portal vein thrombosis
(2), intra-abdominal abcess (1), gastrointestinal hae-
morrhage (1), cardiac arrhythmia (1), acute myocar-
dial infarction (1) and pulmonary embolism (1). The
mortality rate was 6.1% (4/66) during the first half
and 6.8% (12/175) during the second half of the study
period and this difference was not statistically sig-
nificant (p/1.000). None of the patients died in-
traoperatively.
Risk factor analysis
Univariate analysis of various preoperative and in-
traoperative variables that influenced the morbidity
and mortality rates are shown in Tables V and VI,
respectively.
The risk factors for morbidity were age (/50
years), malignant disease, the presence of comorbid
conditions, hypoalbuminaemia, clinical jaundice, a
raised serum creatinine level, hepatitis B surface
antigen positivity, emergency surgery, major intrao-
perative blood transfusion, prolonged surgery (/3
hours), underlying liver cirrhosis, surgery in hepato-
cellular carcinoma with cirrhosis and surgery in gall
Table IV. Operative and perioperative results (n/241).
A Operation time (minutes) 3309/141.2 (110840)
Pringle manoeuvre (yes) 103 (42.7%)
Techniques of resection
Kellyclysis 139 (57.7%)
CUSA 102 (42.3%)
Blood transfusion (units) 2.49/1.6
(08)
Hospital stay (days) 10.19/4.82
(341)
B
Patient suffering ]/1
complication
108 (44.8%)
]/2 complications 38 (15.8%)
Major complications 30 (12.4%)
Surgical intervention
needed
11 (4.6%)
Mortality 16 (6.6%)
Complications No. of
patients
No. of
survivors
Ascites (requiring diuretics or
paracentesis)
24 1
Hepatic insufficiency/failure 17 7
Bile leak/biloma 16 [1] 1
Renal insufficiency/failure* 15 8
Perihepatic fluid collection (sterile) 12 [1] 10
Wound infection
Pleural effusion 9 [2] 2
Sepsis 9 3
Paralytic ileus 5 7
Chest infection
Postoperative intra-abdominal
haemorrhage
5 [2] 2
Respiratory insufficiency/
failure$
4 2
Arrhythmia 4
Portal vein thrombosis 3 [2] 2
Perihepatic abscess 3 [1] 1
Wound dehiscence 3 [1] 1
Unexplained fever 4
Pneumothorax 4 [1] 1
Gastrointestinal tract
haemorrhage
3 1
Persistent hypotension 3
Bronchospasm 2
Congestive heart failure 2
Pulmonary embolism 1 1
DIC (disseminated
intravascular coagulation)
1 1
Hepatic artery embolism and
infarction
1
Note that some patients had more than one complication. Values in
square brackets are numbers of patients who underwent surgical
interventions.
*Prolonged bilirubin level /5 mg/dl unrelated to biliary obstruc-
tion or leak, prolonged coagulopathy requiring fresh frozen plasma
(FFP) and/or hepatic encephalopathy.
$Prolonged ventilatory requirement or re-intubation, hypoxia with
prolonged supplemental oxygen requirement.
Table III. Extent of hepatic resection (n/241).
Resection n (%)
Major resections (/2 segments, n/111)
Extended right hepatectomy (5 segments9/1) 8 (3.3)
Right hepatectomy (4 segments) 54 (22.4)
Left hepatectomy (3 segments) 34 (14.1)
Left extended hepatectomy (49/1 segment) 1 (0.4)
Non-anatomical 3 segment resection 8 (3.3)
B/Bisegmentectomy (non-anatomical resection) 4 (1.7)
Central hepatectomy (39/1 segment) 2 (0.8)
Minor resections (5/2 segments, n/130)
B/Bisegmentectomy (non-anatomical resection) 99 (41.1)
Left lateral segmentectomy (2 segments) 8 (3.3)
Wedge resection (1 segment) 5 (2.1)
Wide local excision/metastatectomy (1 segment) 6 (2.4)
Enucleation/cystopericystectomy 12 (5)
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bladder carcinoma with jaundice. The factors asso-
ciated with increased mortality were the presence
of comorbid conditions, clinical jaundice, raised
serum creatinine levels, deranged prothrombin time,
intraoperative blood transfusion (/3 units), under-
lying liver cirrhosis, common bile duct (CBD) exci-
sion and surgery in hepatocellular carcinoma with
cirrhosis.
All risk factors with p values B/0.1 by univariate
analysis were subjected to stepwise multivariate logis-
tic regression analysis (Table VII). Independent risk
factors for overall morbidity were intraoperative blood
transfusion (/3 units), presence of comorbid condi-
tions, emergency hepatectomy, surgery for malignant
hepatic lesions and severity of resection, while the
independent risk factors for overall mortality were
presence of comorbid conditions and underlying liver
cirrhosis.
Discussion
Hepatic resection has evolved from being a high-risk,
resource-intensive procedure to a mainstream opera-
tion with broad indications. It is now considered
Table V. Univariate analysis of risk factors for overall morbidity after hepatic resection.
Variable
No. of patients with
complications Percentage (%) p value
Age (years) /50 64/119 53.8 0.007*
B/50 44/122 27.9
Gender Male 64/144 44.4 0.896
Female 44/97 45.4
Diagnosis Benign 22/84 26.2 B/0.001*
Malignant 86/157 54.8
Comorbid medical conditions No 60/164 36.6 B/0.001*
Yes 48/77 62.3
Clinical jaundice No 74/189 39.1 0.001*
Yes 34/52 65.4
Preoperative serum bilirubin (/10 mg) No 92/216 42.6 0.055
Yes 16/25 64
Preoperative serum creatinine (/1.3 mg/dl) No 98/229 42.8 0.007*
Yes 10/12 83.3
Preoperative serum albumin Normal (/3.5 g/dl 68/172 39.5 0.010
Subnormal (B/3.5 g/dl) 40/69 58
Preoperative platelet count /150 000 96/217 44.2 0.667
B/150 000 12/24 50
Prothrombin time Normal 95/219 43.3 0.181
Deranged 13/22 59.1
HBsAg status No 83/200 41.5 0.006*
Yes 12/15 80
Extent of hepatic resection Minor (5/2 segments) 52/130 40 0.119
Major (/2 segments) 56/111 50.5
Complex hepatectomy No 62/155 40 0.058
Yes 46/86 53.5
Bile duct excision No 76/181 42 0.136
Yes 32/60 53.3
Elective/emergency Elective 99/229 43.2 0.038*
Emergency 9/12 75
Liver cancer with cirrhosis No 94/226 41.6 B/0.001*
Yes 14/15 93.3
Gall bladder cancer with jaundice No 88/213 41.3 0.004*
Yes 20/28 71.4
Pringle manoeuvre No 55/138 51.5 0.089
Yes 53/103 39.9
Intraoperative blood transfusion No 8/36 22.2 0.003*
Yes 100/205 48.8
Intraoperative blood transfusion (units) B/3 units 46/141 32.6 B/0.001*
/3 units 62/100 62
Techniques of resection Kellyclysis 59/139 42.8 0.513
CUSA 49/102 47.6
Duration of surgery /180 min 97/200 43.9 0.015*
B/180 min 11/41 26.8
Liver pathology Non-cirrhotic 91/221 41.2 B/0.001*
Cirrhotic 17/20 85
Year 19962000 36/66 54.5 0.081
Year 20012005 72/175 41.1
*Significant p value.
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to be the most effective treatment for selected
patients with primary and secondary hepatobiliary
malignancies and is the only effective treatment for a
number of benign hepatic diseases [2,712]. This
evolution has largely been due to the progressive
improvement in the morbidity and mortality rates. In
developing countries in South Asia, however, hepatic
resection is still not performed routinely in most
centres because it is viewed as being a difficult
procedure associated with major blood loss and
postoperative complications. Thus, to our knowl-
edge, there have been no large reports on consecu-
tive hepatic resections published from this part of the
world.
At our centre we started performing liver resections
in 1996 and have an active living donor liver
transplant programme, so we felt that it might be
worthwhile to analyse our prospectively maintained
database to compare our results with those reported
from other major centres, to determine which factors
Table VI. Univariate analysis of risk factors for overall mortality after hepatic resections.
Variable
No. of patients with
complications Percentage (%) p value
Age (years) /50 11/119 9.24 0.126
B/50 5/122 4.10
Gender Male 10/144 6.9 1.000
Female 5/97 5.1
Diagnosis Benign 3/84 3.57 0.1870
Malignant 13/157 8.28
Comorbid medical conditions No 5/164 3.05 0.004*
Yes 11/77 14.28
Clinical jaundice No 8/189 4.23 0.009*
Yes 8/52 15.38
Preoperative serum bilirubin (/10 mg) No 13/216 6.01 0.223
Yes 3/25 12
Preoperative serum creatinine (/1.3 mg/dl) No 13/229 5.67 0.037*
Yes 3/12 25
Preoperative platelet count /150 000 13/229 5.67 0.204
B/150 000 3/24 12.5
Prothrombin time Normal 12/219 5.48 0.046*
Derranged 4/22 18.18
HBsAg status No 13/200 6.5 0.089
Yes 3/15 20
Extent of hepatic resection Minor (5/2 segments) 9/130 6.92 1.000
Major (/2 segments) 7/111 6.30
Complex hepatectomy No 8/155 5.16 0.280
Yes 8/86 9.30
Bile duct excision No 8/181 4.42 0.031*
Yes 8/60 13.33
Elective/emergency Elective 15/229 6.55 0.570
Emergency 1/12 8.33
Liver cancer with cirrhosis No 11/226 4.87 0.001*
Yes 5/15 33.33
Gall bladder cancer with jaundice No 12/213 5.63 0.099
Yes 4/28 14.28
Pringle manoeuvre No 8/138 5.80 0.606
Yes 8/103 7.76
Intraoperative blood transfusion No 2/36 5.55 1.00
Yes 14/205 6.82
Intraoperative blood transfusion (units) B/3 units 5/141 3.54 0.033
/3 units 11/100 11
Techniques of resection Kellyclysis 9/139 6.47 1.000
CUSA 7/102 6.86
Duration of surgery (min) B/180 3/41 7.38 0.740
/180 13/200 6.5
Liver pathology Non-cirrhotic 10/221 4,52 0.001*
Cirrhotic 6/20 300
Year 19962000 4/66 6.06 1.000
Year 20012005 12/175 6.86
*Significant p value.
34 S. Marwah et al.
were associated with morbidity and mortality and to
examine whether increasing experience had shown
any improvement in results.
Our postoperative mortality rate for liver resection
of 6.6% is comparable with recently published
Western and Far Eastern figures of 5.8% to 8.4%
[3,6].
We had a morbidity rate of 44.8% of cases and
although this figure seems unduly high it is compar-
able with that of large series published previously
[3,5,13]. However, life-threatening complications oc-
curred in only 12.4% of the cases. The main causes of
postoperative morbidity were ascites, transient hepatic
insufficiency and minor bile leaks. Although they
prolonged the postoperative recovery period, these
problems usually settled with conservative treatment
and were rarely responsible for the mortality.
To assess the effect of experience in the procedure
we analysed the results of hepatic resections during
the first and second period of the study. We observed
that despite a large increase in the number of major
resections, as well as the complexity of the hepatic
resections performed, the morbidity rates decreased,
although not significantly, during the second period.
However, mortality rates remained the same. Similar
results despite adding more complex resections have
been reported by other authors [3,11,14,15], and the
lack of improvement in mortality rates may also be
due to the extended indications for the procedure.
Several reports have compared the morbidity and
mortality rates among high volume (performing 10 or
more hepatic resections per year) and low volume
centres [6]. These reports suggest that mortality rates
are significantly lower (1.56.2%) in high volume
centres compared with low volume centres (3.7
24.4%) [1618]. It is implied that because high
volume centres have greater experience they provide
care of a superior quality and therefore have a lower
incidence of postoperative complications and death.
However, as there are also reports showing a very low
mortality from some low volume centres [1921], we
feel that other units should be encouraged to perform
hepatic resections  especially in developing countries
where the patient may not be able to reach or afford
high volume centres. With judicious patient selection
and meticulous surgical techniques they are likely now
to achieve results comparable to those of large volume
establishments.
The average median length of hospital stay after
surgery for our patients was 10.2 days, which is
comparable with that in other reported series which
varied from 7 to 9.7 days [6,13,21]. Perhaps the wider
use of laparoscopic hepatic resections will shorten
the stay further to a mean of 2.9 days (range 114
days) [22].
One of the most important outcomes of our study
was the identification of the independent risk factors
for overall morbidity and mortality. These were the
presence of comorbid conditions, hepatic cirrhosis,
carcinoma of the gall bladder with jaundice, extent of
hepatic resection and large intraoperative blood
transfusion (/3 units). This corroborates the findings
in previous studies [3,6,13,14,23,24].
Our experience with hepatic resection in a specia-
lized unit in India shows that with careful patient
selection, scrupulous perioperative management of
comorbid conditions and meticulous surgical dissec-
tion with either Kellyclasis or CUSA to minimize
blood loss and blood transfusion requirements, major
and complex hepatic resections can be performed
safely in third world countries like India, with results
comparable to those reported from the western world
or South-east Asia.
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